A multicenter, open-label, randomized, proof-of-concept phase II clinical trial to assess the efficacy and safety of icatibant in patients infected with SARS-CoV-2 (COVID-19) and a...

Por Pierre Malchair, Aurema Otero, Jordi Giol, Xavier Solanich, Thiago Carnaval, Alonso Fernández-Nistal, Ana Sánchez-Gabriel, Carmen Montoto, Ramon Lleonart, Sebastián Videla, on behalf of the ICAT-COVID team
Publicado em 2022-04-01

Biomarkers and clinical scores to identify patient populations at risk of delayed antibiotic administration or intensive care admission

Por Juan Gonzalez del Castillo, Darius Cameron Wilson, Carlota Clemente-Callejo, Francisco Román, Ignasi Bardés-Robles, Inmaculada Jiménez, Eva Orviz, Macarena Dastis-Arias, Begoña Espinosa, Fernando Tornero-Romero, Jordi Giol-Amich, Veronica González, Ferran Llopis-Roca, on behalf of the INFURG-SEMES investigators
Publicado em 2019-10-01